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The concept of using stem cells as self-renewing sources of healthy cells in regenerative medicine has existed for
decades, but most applications have yet to achieve clinical success. A main reason for the lack of successful stem
cell therapies is the difficulty in fully recreating the maintenance and control of the native stem cell niche. Im-
proving the performance of transplanted stem cells therefore requires a better understanding of the cellular
mechanisms guiding stem cell behavior in both native and engineered three-dimensional (3D) microenvironments.
Most techniques, however, for uncovering mechanisms controlling cell behavior in vitro have been developed
using 2D cell cultures and are of limited use in 3D environments such as engineered tissue constructs. Deciphering
the mechanisms controlling stem cell fate in native and engineered 3D environments, therefore, requires rigorous
quantitative techniques that permit mechanistic, hypothesis-driven studies of cell–microenvironment interactions.
Here, we review the current understanding of 2D and 3D stem cell control mechanisms and propose an approach
to uncovering the mechanisms that govern stem cell behavior in 3D.
Challenges with the Therapeutic Application
of Stem Cells
Stem cells are defined by their ability to both self-renew and differentiate by undergoing asymmetric cell
divisions. This unique behavior is made possible by the
specialized, three-dimensional (3D) microenvironment that
immediately surrounds them in native tissue. These niches
provide the structural, biochemical, mechanical, and stimu-
latory cues necessary for the appropriate functioning of stem
cells during homeostasis and in response to physiological
change.1,2 In this way, stem cells are defined by their 3D
anatomical location, and when we remove them from it, we
create derivatives that have altered functionality, phenotype,
and responsiveness to environmental cues. Even given these
challenges, stem cells have been used in both preclinical and
clinical studies, and there is substantial promise in their use
for the purpose of regenerating diseased or injured tissues.3–8
However, there are many potential dangers in the clinical
application of stem cells when the appropriate character-
ization, manipulation, sourcing, and quality control are not
adequately performed.9–11
In 2005, a 13-year-old boy with ataxia telangiectasia, a he-
reditary neurodegenerative disease, presented with recurrent
headaches after receiving three stem cell transplantations in
Moscow, at the ages of 7, 10, and 12. Investigation into the
cause of the headaches by magnetic resonance imaging re-
vealed a multifocal brain tumor.12 The tumor was of nonhost
origin and therefore from the implanted cells that were de-
rived from at least two different donors.12 The cells that were
injected into the patient were described as ‘‘fetal neural stem
cells’’; however, the exact nature of the cells was unknown,
and it is not clear whether appropriate quality control and
safety and effectiveness studies had been performed.
The devastating result of this stem cell procedure high-
lights the gap that still exists between our understanding of
how a stem cell behaves in vivo in the niche and its unpre-
dictability outside of that niche. The International Society for
Stem Cell Research responded to this case with a call to
emphasize the importance of rigorous and consistent pre-
clinical trials on the safety and effectiveness of stem cell
treatments.13 Mimicking the control present in the native
stem cell niche is necessary to achieve consistent and effec-
tive application of stem cells in the clinic; however, the
spatial and temporal mechanisms that specifically govern
stem cell fate determination within these environments re-
main unclear.
Embryonic stem cells are commonly regarded as the gold
standard for regenerative therapies because they are plu-
ripotent: there are no totipotent stem cells, as none have
demonstrated replication of the placenta. However, the sheer
number of environmental cues and mechanisms required for
directing specific fate determination has made them difficult
to control in vitro and in vivo. Further, their potential intro-
duces complexity in defining and testing these mechanisms.
Multipotent mesenchymal stem cells (MSC), on the other
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hand, have restricted potential as compared to embryonic
stem cells, lending simplicity to their differentiation decision.
Additionally, the variety of sources available, including bone
marrow,14 cartilage,15 fat,16 lung,17 ligament,18 brain, spleen,
liver, kidney, muscle, thymus, pancreas, and more,19 provides
multiple starting points for unique applications in tissue
engineering. Further, induced pluripotent cells are cells ge-
netically reprogrammed to regenerate pluripotency from
various adult tissue cell types. Using this technology, patient-
specific induced pluripotent cells can be derived from mature
cell types and show potential in drug screening and for the
development of disease models.20
The key challenge for all these cell types, however, remains
the same, providing the proper environmental cues to regu-
late the balance between differentiation and self-renewal.
Functional tissue engineering will require an understanding
of how the niche controls stem cell function, application of
those principles to synthetically mimic that niche in 3D, and
novel methods of data acquisition and analysis to feed de-
scriptive and predictive models of tissue function. Execution
of these aims will require an increasingly interdisciplinary
approach to tissue biology and engineering.
Directing Stem Cell Differentiation and Self-Renewal
Stem cells derive their behavior from cues that lie in their
extracellular environment. These cues operate on different
spatial and temporal scales to pattern specific cellular be-
haviors that drive tissue morphogenesis and differentiation.
A wealth of knowledge, gathered in the last several decades,
characterizes stem cell phenotype and function as well as
presents methods to direct their differentiation along specific
lineages in response to these extracellular cues. Within this
context, the extracellular matrix (ECM), soluble growth fac-
tors, cell–cell interactions, and mechanical stimuli combine to
coordinate the in vivo tissue response on multiple scales
creating overlapping influences that are differentiated by the
scope of their impact. In vitro, these distinct stimuli can be
employed in a controlled fashion to both direct and mecha-
nistically understand stem cell fate determination.
Extracellular matrix
The ECM not only serves to provide structural and orga-
nizational guides for tissue development but also defines and
maintains cellular phenotype and drives cell fate decisions.
Cells are surrounded by a complex architecture of proteins,
polysaccharides, and proteoglycans that constantly undergo
dynamic change as a result of assembly, remodeling, and
degradation events. The flexibility inherent in this structure
allows the microenvironment to be tuned on a cell-by-cell
basis in response to unique patterns of protein secretion and
modification. Adhesion to the specific components of the
ECM via integrins, cadherins, and discoidin domain receptors
activate signaling programs sensitive to the composition and
orientation of that ECM.21 In vitro, MSC produce and use
applied ECM to promote their own expansion and inhibit
spontaneous and uncontrolled differentiation.22 The ECM also
plays a critical role in defining cell shape, which in turn affects
cell survival,23 proliferation,24 and differentiation,25 and these
roles have also been confirmed in vivo. For example, integrins
not only help to position germ stem cells within their niche but
also provide feedback between those cells and the extracel-
lular environment. Loss of integrin function in the germ stem
cells niche of adult Drosophila melanogaster testis prevents
the proper deposition, organization, and composition of the
ECM.26
Soluble cues
In vivo, soluble factors, such as peptide growth factors
and hormones, play a significant role in directing stem cell
fate. These factors diffuse through and are sequestered by the
ECM and bind to cell surface receptors activating cellular
function. Interactions with the ECM restrict the effect soluble
factors can have on the cell population creating overlapping
spheres of influence that are ultimately controlled by the cell
through tuning of the ECM. Additionally, the acute but
transient nature of growth factor signaling is directly con-
trasted to the slow but sustained signals received from the
ECM. For example, when induced to differentiate in restric-
tive ECM environments, adhesive, flattened cells preferen-
tially adopt an osteogenic phenotype and round cells tend
toward adipogenesis.25 Additionally, restricting the dynam-
ics of the actin cytoskeleton, which coordinates intracellular
signal transduction with cues in the ECM, promotes osteo-
genesis irrespective of soluble adipogenic induction. In this
way, the ECM primes cells to bias their interpretation of
extracellular soluble factors into internal signals.
Cell–cell communication and positioning
Juxtacrine cell–cell communication, propagated by the
physical association of two cells, provides a persistent mor-
phogenic cue, while the diffusion of soluble signals from
neighboring cells, paracrine signaling, transiently affects
proximal populations of cells. The method of association be-
tween neighboring cell populations represents a significant
difference in commitment to cooperate. These interactions
between cell populations influence a range of stem cell be-
havior, including the induction of programs of differen-
tiation27,28 and promotion of expansion and self-renewal
properties.29–31 Mature cell populations physically associate,
through adherens junctions, with stem cells in the native
niche. For example, osteoblasts interact with hematopoietic
stem cells in the bone marrow, endothelium regulates neural
stem cell differentiation in the brain, and MSC promote he-
matopoietic stem cells’ self-renewal.32–35 Additionally, posi-
tioning within the stem cell niche, achieved by both cell–cell
contacts and the spatial distribution of the ECM, physically
restricts stem cell self-renewal and differentiation behavior
by directing the position of the mitotic axis in asymmetric
division.36,37
Mechanical stimulation
Overlaid on all of these mechanisms is the mechanical en-
vironment that governs ECM interactions, changes sensitiv-
ities to soluble cues, and physically distorts cell populations
within tissues. As a global cue, the mechanical environment
influences all aspects of tissue behavior, since essentially all
cells, with the exception of circulating blood cells, are an-
chorage dependent and require interaction with the ECM
to maintain viability. When adherent, cells are able to exert
contractile forces on their environment and sense compliancy
to induce appropriate cellular behavior.38 Even cells within
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soft tissues exhibit these characteristics and the patterning of
mechanical forces throughout development guides morpho-
genesis.39 In particular, matrix elasticity directs stem cell dif-
ferentiation where 2D substrates, modeled to closely replicate
in vivo tissue compliance, are more efficient in promoting their
specific lineage commitment.40 Similarly, in clusters of MSC,
commitment is location specific, with cells in areas of high
stress (edges) becoming osteogenic and those under low stress
(interior) assuming an adipogenic profile.41 In addition, stem
cells respond to fluid flow–induced shear stresses,42,43 com-
pressive and tensional strains,44,45 cyclical stretching,46–49 and
hydrostatic pressures.50
The Limitations of 2D Culture
Most of the above work has been performed in 2D culture
systems, and while these systems present useful and pow-
erful methods for probing cellular behavior, many of these
studies are difficult, if not impossible to confirm in vivo.
These elegant 2D systems allow for the precise control of cue
presentation; however, our tendency to simplify the cellular
environment detracts from the richness of the data we gen-
erate. Even grown in monolayer (2D), cells are still 3D
structures and are influenced by the entirety of their envi-
ronment. Embracing the complexity of these data sets can
only be achieved through advances in the generation of
quantitative models to operate on and represent the data, but
there also exists a point where 2D culture is limited in its
ability to ask questions about the complex spatial and tem-
poral patterning of these cues like that seen in vivo. In ad-
dition, it is clear that the three-dimensionality of tissue is
essential for the maintenance of cellular function and the
development of physiologically relevant structures. Three-
dimensional matrices in vitro and in vivo define the struc-
tural, mechanical, and biochemical make-up of the cellular
microenvironment and are crucial for allowing a bidirec-
tional interplay to exist between the cell and tissue during
development.51 While cells on rigid, planar surfaces can re-
spond to the mechanical nature of the culture system, they
have little capacity to manipulate the composition and me-
chanical properties of the ECM itself.52 Mature cells cultured
in 3D matrices exhibit altered phenotypes inhibiting their
proliferative nature and enhancing their ability to form
higher order structures.53 This 3D context also enhances stem
cell potential by permitting the dynamic interfacing of the
differentiating stem cell with its matrix.54
Promising Leads in 3D Biomaterial Engineering
Approaching the problem of controlling cell and tissue
function from a different mindset, biomaterials scientists and
bioengineers generate constructs that mimic the structure and
function of the end tissue product in 3D. This alternative ap-
proach critically links 2D mechanistic studies to the in vivo
application; however, the mechanisms of cellular interaction
and subcellular functioning within these environments are
not well known. Using both natural (protein and polysac-
charide) and synthetic polymers, material scientists can en-
gineer patterns of adhesion,55,56 composition,57,58 growth
factor59–61 and mechanical gradients,62,63 cell positioning,64–68
degradation rates,69–72 and geometry73 to direct tissue mor-
phogenesis.74–77 The application of these materials with a
cellular component has been well reviewed recently for a
range of tissue targets, including, but not limited to, bone,78–80
cardiac,81,82 tendon,83,84 nerve,85,86 cartilage,87,88 and fat.89–91
Within these artificial environments engineers demon-
strate elegant control over cellular function; however, the
rationale for their approach has largely been based upon
sophisticated trial and error, which lacks efficiency in sur-
veying a range of microenvironments. This biomaterial
toolkit, however, provides a powerful mechanism through
which one can translate sophisticated 2D experimental de-
sign into complex 3D microenvironments. Using engineering
biomaterials with tunable physical, chemical, and biological
properties as control signals allows the uncoupling of these
signals to reduce the complexity of the 3D system. This
opens a door for engineers to take a step back from clinical
application and use their tools to advance the understanding
of tissue biology and disease progression and provide tools
for biologists to begin testing mechanistic hypotheses in 3D
culture. In this way, we begin to bridge the disconnect that
exists between 2D signaling studies and tissue engineering
and engraftment.
Translating Mechanism into 3D
The rigorous and reductionist signal transduction studies
that are performed in 2D and the biomaterial-based appli-
cation of stem cells in vivo are inherently disconnected by our
lack of understanding of the effect dimensionality has on
cellular decision making. Tissue engineering is limited by the
amount of complexity it can understand and control, and
achieving higher levels of understanding requires mecha-
nistic probing of complex models in 3D. Though based upon
highly educated guesses, the lack of mechanistic hypotheses
that can guide the development of these biomaterials limits
their utility in these types of studies. What is fundamentally
needed to further this field is a predictive and descriptive
model that governs stem cell–material interactions and tissue
development. Reaching this point will require a more effi-
cient fusion of rigorous and mechanistic studies and the
novel methods of controlling cellular function in 3D. Using
this idea, the field of ‘‘cell instructive artificial ECM’’ has
emerged to augment biologically inert polymers with spe-
cific bioactivity, and thereby define the local microenviron-
ment based upon biological hypotheses.92 For example,
bioactive, synthetic hydrogel matrices exploit the activity of
vascular endothelial growth factor (VEGF) to induce local,
controlled angiogenesis. VEGF tethered to the artificial ma-
trix is restricted by the matrix until cell-mediated enzymatic
degradation of the ECM, thereby coupling cell remodeling
processes with local concentrations of VEGF.59,93 In this way,
tissue components are dynamically related to each other and
the active interplay may be more important in guiding de-
velopment than the quantitative amount of cells and stimuli
present within the tissue.
However, there are still significant limitations in the ap-
plication of rigorous 2D techniques into the study of 3D signal
transduction in the traditional sense. For this reason, few
groups have successfully extended the well-developed 2D
signal transduction field onto 3D scaffolds94–99 and even
fewer in the field of stem cell biology.54,100,101 Instead, dem-
onstration of biomaterial performance has primarily relied
upon imaging technologies, morphological studies, histology,
and bulk material properties. Many of these methods are
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inherently qualitative and do not readily contribute to
achieving higher throughput efficiencies.
Developing complex models that couple mechanical and
biochemical cues to achieve a phenotype more closely related
to that found in vivo will be a critical component of tissue
biology and engineering moving forward. In fact, the field of
tissue engineering is additionally turning its attention to the
development of physiologically relevant models of diseased
tissue.102–105 Many of the tools available for the development
of these types of complex environments have been well re-
viewed elsewhere.51 Engineering consistency and ease of use
into these models will facilitate their widespread adoption by
cell and molecular biologists as well as bioengineers. The
rigorous signal transduction work, done in basic biology
labs, and the complexity being introduced by engineers will
jumpstart a powerful understanding of the 3D environment
and its role in regulating cell function.
Developing these complex microenvironments for both
mechanistic studies and clinical application is not trivial. The
combinatorial complexity of incorporating various ECM
proteins, signaling molecules, mechanical stimuli, and het-
erogeneous cell populations in different spatial and temporal
patterns creates an enormously large search space from which
to begin the engineering of new tissue constructs. In addition,
the lack of biologically based, mechanistic hypotheses in 3D to
inform these choices prevents efficient material development.
These problems of scope and throughput require novel
methods of analysis that provide quantitative metrics to direct
decision processes in early material engineering and decrease
this search space.
3D Modeling of Complex Networks and Cell Function
From the single-cell level up to the level of developing
tissue and organization dynamics, development of models
that quantitatively capture the principles guiding each tier of
decision making is an emerging field that has the potential to
accelerate tissue engineering efforts. The iterative generation
of biological hypotheses and development of new biomate-
rials based upon those hypotheses is required for effective
clinical translation. Developing methods of efficiently closing
this ‘‘tissue engineering loop’’ necessitates rigorous quantita-
tive methods for analyzing the spatio-temporal function of
cells and tissues (Fig. 1). Quantitative model analysis provides
feedback to inform engineering design by testing these hy-
potheses and improving the throughput of material optimi-
zation. There are three levels of tissue function that can be
modeled to better understand the dynamic, multiscale inter-
actions: these levels include analysis of the (1) single cell, (2)
cells and their neighborhood, and (3) whole tissues (Fig. 2).
Modeling of the single cell involves the complex interaction
of signal transduction pathways, cellular differentiation, as
well as spatial and morphological information captured by
imaging techniques. The cell signaling that leads to changes in
cellular behavior and differentiation is a complex and non-
linear network of protein interactions and genetic regulation
that, even in 2D, becomes far too complex for traditional
methods of data analysis. As relatively few signaling mole-
cules can interact and form thousands and even millions of
distinct signaling species, the complexity of these networks
requires advanced methods of data mining.106 Computational
modeling has presented an approach to understanding net-
work dynamics that defines system function and dysfunction
and additionally provides predictive capabilities.107,108 These
methods have been well reviewed106,109–111 and have pro-
vided insight into the dynamics of specific signaling path-
ways, interactions between soluble cues, and intracellular
interactions.112–120 Additionally, the generation of quantifi-
able metrics that can define morphological and signaling
features at the cell level will facilitate their entry as parameters
into predictive and descriptive multiway modeling analyses.
The inner machinery that governs the individual cell exists
on a separate temporal and spatial scale as compared to
the interactions those cells have with their local microenvi-
ronment. Imaging, particularly in 3D, is a powerful tool for
cell biologists and engineers and has been used to provide
spatial information regarding the location of specific struc-
tures within the cellular microenvironment. Critical to the
FIG. 1. Engineering effi-
ciency into the tissue engi-
neering loop. Successful
clinical application of basic
biology and biomedical engi-
neering research is dependent
upon the efficient and directed
development of new products.
Current efforts in the field of
biomaterial development are
based loosely on biological
hypotheses but are largely
sophisticated trial-and-error
experiments. We can more
efficiently move through this
process using biomaterials
to develop complex three-
dimensional (3D) microenvi-
ronment models that generate
data to feed into descriptive
and predictive models. The quantitative metrics that emerge from these models will enable the generation of new mechanistic
biological hypotheses based on complex 3D data. Iterating through this loop will create rational approaches to biomaterial
development and quantitative metrics that will evaluate material performance and drive further optimization.
374 LUND ET AL.
throughput and effectiveness of imaging studies, however, is
the development of methods for quantitative and automated
analysis of 3D multi-spectral images over time (5D). For ex-
ample, the use of a series of image sequences to automatically
track cell lineage during proliferation and migration provides
a wealth of information from positioning, shape, cell–cell
contacts, motility, ancestry, and temporal relationships that
would be difficult to quantify by hand.121 Analysis of the
neural stem cell niche using automated image analysis per-
mits the identification of functionally labeled cells, quantifies
cell–cell interactions, and determines cellular proximity to
specific structures.122 Inhibition of specific interactions within
this model results in the detection of quantitative shifts in cell
positioning and proliferation. This work must move toward
methods of membrane segmentation and feature definition to
extract the interactions between neighboring cells as well as
the resources present within the ECM for which they compete.
Additionally, tissue engineers employ the use of computa-
tional modeling to understand the relationship between cel-
lular behavior and physical forces such as fluid flow, stresses,
and strains (i.e., within bioreactors).123
The expansion of the image analysis and quantitative
modeling field has, however, allowed us to step even farther
out from subcellular localization and microenvironment in-
teractions to global tissue organization and development. The
coordination of interaction between cells and their matrix
defines tissue structure and function, therefore, the spatio-
temporal quantification of these interactions will provide
insight into population dynamics and cooperation within
developing tissues. Several groups have begun to apply
quantitative methods to understanding differentiation, mor-
phogenesis, and remodeling by developing models that pre-
dict the sprouting location of branching tubules in 3D type I
collagen culture based upon the geometry of the starting
FIG. 2. Multiscale modeling of cell and tissue function. Cells and tissues function across variable time and spatial scales.
Capturing quantitative information at each of these stages and modeling the changes observed are critical steps toward closing
the tissue engineering loop. Each field encompassed by this work contributes at the spatial scales described above, but as of yet
we are unable to fully integrate the information generated at each level to create a cohesive and dynamic picture of the tissue
system. Biologists (BIOL) and biomedical engineers (BME) each look across these time scales using a variety of different tools.
Bringing these techniques together to reintroduce complexity into 3D cell culture models will aid the development of mechanistic
hypotheses that are better able to explain the complexity inherent in physiological structures. Integrating the quantitative tools
developed by computer scientists (CSCI) with this 3D data over time will provide quantitative metrics to further inform the
design of new materials and culture systems and promote their predictability in the clinical setting. Color images available
online at www.liebertonline.com=ten.
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structure.124 Another approach based on graph theory and
machine learning when applied to tissue structure enables the
extraction of parameters that define function and dysfunction
in terms of the structural organization of cell nuclei and aids
pathology diagnosis.125–128 These cell graphs have also re-
cently been applied to 3D fluorescent images of compacting
type I collagen hydrogels, with encapsulated MSC, resulting
in the extraction of cellular patterns that govern the spatio-
temporal progression of tissue organization in the early stages
of MSC culture, matrix remodeling, and differentiation (Lund
et al., recently submitted). To further describe the network
dynamics of developing tissues, 3D cell-graphs can be en-
hanced through the quantification of the microenvironment.
This method allows for the tracking of ECM dynamics,
influenced by MSC, at early time points to identify critical
stages of type I collagen remodeling and organization. These
stages represent distinct phases with late remodeling events
in untreated cells clustering strongly with early phases of re-
modeling by differentiating cells (Bilgin et al., recently sub-
mitted). These methods, taken together, allow us to link
engineered tissue structure with tissue maturation and cel-
lular differentiation at multiple scales within a developing
tissue and to extract metrics that define these dynamic in-
teractions. Macroscopic tissue spatial distributions are not
random. The specific structures present within tissues are
developed to support specific function, and therefore under-
standing the microstructure of developing and diseased tissue
will be predictive of function.
The quantitative metrics that emerge from these fields can
help to define design targets for efficient engineering of the
cell–biomaterial interface and will provide an important and
quantifiable link between biological hypotheses and bioma-
terial performance (Fig. 1). Understanding the early events,
both structural and biochemical, that are predictive of long-
term functional outputs will increase the throughput, cost-
effectiveness, and consistency of biomaterial development by
decreasing the search space. Moving forward we must fur-
ther facilitate the interaction between these different mind-
sets to establish a new paradigm for the tissue engineering
approach.
Moving Forward
There is, however, a data bottleneck in place hindering the
implementation of these techniques. Discrepancies exist be-
tween the reductionist methodology that reduces complexity
by considering fewer data points, and computational tech-
niques that become rigorous only as data volume increases.
Biologists have successfully reduced biological complexity to
an endless variety of minute parts; however, our ability to
translate the minutia of signaling, protein folding, and gene
expression into the complexity of development, differentia-
tion, and disease progression depends on understanding their
complex multiscale relationships. Computational techniques
such as data mining, knowledge discovery, and machine
learning can be developed to discover such relationships;
however, they require large volumes of multimodal data to be
rigorous, which is currently limited by the reductionist par-
adigm.
By both adapting traditional 2D assays and creating new
methods for analysis that capitalize on imaging modalities,
biologists and engineers can approach questions of cellular
function and dysfunction as a 3D system. However, to do
so in a manner that supports the modeling and rigorous sta-
tistical standards of computer science we must also engineer
methods of high-throughput that can expand biochemical
and imaging outputs into large data sets sampled over time
and on different scales. In breaking this data barrier there
comes an additional practical complexity where the ‘‘fast’’
algorithms developed for current problems will not be fast
enough. Linear time algorithms will not be able to handle the
quantity and complexity of data that can be generated by
advancements in biological and engineering throughput.
Genomics data, for example, consume 3–4 mega terabytes of
memory and require sublinear (e.g., logarithmic) time algo-
rithms. Another computational challenge that comes from
breaking the data bottleneck is the difficulty of representing
multimodal, multiscale data in such a way that fast knowl-
edge extraction and data mining algorithms can operate.
Techniques for multiway data analysis (e.g., tensor decom-
positions) can be deployed for such representation and anal-
ysis; however, their computational complexity prohibits their
applicability. Thus, the challenge in designing fast knowledge
extraction and data mining algorithms to operate on and
represent this complex data set is to generate novel algorithms
that efficiently run through and integrate complex, multiscale
data (i.e., tensor analysis). A coordinated interdisciplinary
effort will be required to address all the components of this
proposed approach and will generate a multiscale analysis of
cell and tissue organization and interaction over time. De-
scriptive and predictive models of this process will lead to
improved efficiencies in material optimization for engineered
tissue products and increased control over their ultimate
structure, function and viability in vivo.
Conclusions
Stem cells present an incredibly flexible technology that has
application in tissues as varied as fat, nerve, and bone and
disease states from diabetes to cancer and Crohn’s disease.
However, accelerating their adoption in the clinical setting
must be done carefully, to avoid detrimental outcomes that
could damage long-term clinical acceptance. The rigorous
characterization of stem cell behavior, as a function of their
various tissue sources, is necessary to ensure safety and effi-
cacy in vivo. However, the intimate relationship between stem
cells and their 3D extracellular environment must be consid-
ered in this analysis, and to this point, doing so remains
technologically challenging. The biasing of stem cell function,
which occurs with traditional methods of 2D culture, leads to
unpredictable in vivo results that hamper translation into the
clinic. Developing novel methods to test mechanistic hy-
potheses in engineered 3D microenvironments will guide the
translation of the control present in the native stem cell niche
to functional tissue engineering products and create more
predictable, consistent, and safe technologies.
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